NFKB1 and hepatocellular carcinoma: The present study further elucidated the molecular mechanism underlying acetate-mediated inhibition of HCC progression, demonstrating that acetate exerts anti-inflammatory and antitumor effects primarily through activation of the GPR43 receptor and suppression of the NF-κB pathway.